Although cell signaling studies are desirable for further evaluation of SR18 for obvious reasons, as an alternative, the agonistic potential of SR18 was preliminarily evaluated using computational structural biology techniques instead
Participants on the 12 mg dose reached roughly 24% mean body-weight reduction from baseline, the largest figure reported for an incretin-based compound in a trial of this length [1]
Ready to see if you qualify
Solvent & Solubility In Vitro : H 2 O : 62.5 mg/mL ( 203.37 mM
If you experience sudden complete vision loss, a large dark shadow blocking your sight, or eye pain with vision changes after hours or on weekends, go to the emergency room
Mild GI effects (nausea, fullness) as your body adapts